AstraZeneca taps RenalytixAI for personalized kidney medicine initiative at Mount Sinai
AstraZeneca has enlisted RenalytixAI to help it develop precision medicine strategies for managing patients with chronic diseases of the cardiovascular system, kidneys and metabolism.